Published in Circulation on September 06, 2005
Impact of relative contraindications to home management in emergency department patients with low-risk pulmonary embolism. Ann Am Thorac Soc (2015) 1.46
Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care (2008) 1.13
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Des Devel Ther (2009) 1.05
The role of ST-segment elevation in lead aVR in the risk assessment of patients with acute pulmonary embolism. Clin Res Cardiol (2011) 1.01
Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers. Vasc Health Risk Manag (2009) 0.91
Interpretation and use of natriuretic peptides in non-congestive heart failure settings. Yonsei Med J (2010) 0.88
Risk stratification in pulmonary embolism based on biomarkers and echocardiography. Circulation (2005) 0.85
Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism. Multidiscip Respir Med (2013) 0.83
A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol (2012) 0.81
Thrombus load and acute right ventricular failure in pulmonary embolism: correlation and demonstration of a "tipping point" on CT pulmonary angiography. Br J Radiol (2012) 0.76
The Risk-based Treatment of Acute Pulmonary Embolism. J Clin Med Res (2009) 0.76
Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. J Cell Mol Med (2013) 0.76
Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine. Biomark Insights (2008) 0.75
Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart (2015) 0.75
New prospective for the management of low-risk pulmonary embolism: prognostic assessment, early discharge, and single-drug therapy with new oral anticoagulants. Scientifica (Cairo) (2012) 0.75
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulm Med (2017) 0.75
Right ventricular myocardial infarction and pulmonary embolism differential diagnosis--a challenge for the clinician. J Med Life (2010) 0.75
Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism. Scand J Trauma Resusc Emerg Med (2012) 0.75
Significance of serum cardiac troponin I levels in pulmonary embolism. J Thorac Dis (2012) 0.75
Comparison of PESI, echocardiogram, CTPA, and NT-proBNP as risk stratification tools in patients with acute pulmonary embolism. Indian Heart J (2016) 0.75
Predicting in-hospital death during acute presentation with pulmonary embolism to facilitate early discharge and outpatient management. PLoS One (2017) 0.75
Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate. Intern Emerg Med (2016) 0.75
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med (2005) 12.72
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med (2002) 8.28
Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med (2007) 5.65
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology (2003) 4.13
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet (2012) 3.66
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol (2011) 3.13
Moderate hypothermia for severe cardiogenic shock (COOL Shock Study I & II). Resuscitation (2012) 2.70
Calcium cycling in congestive heart failure. J Mol Cell Cardiol (2002) 2.46
Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J (2005) 2.34
JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica (2008) 2.05
Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol (2003) 2.01
The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int (2010) 1.96
Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation (2005) 1.93
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci U S A (2002) 1.88
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.80
Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium. Circulation (2002) 1.73
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation (2009) 1.71
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace (2011) 1.70
Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost (2008) 1.70
Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation (2011) 1.68
Indications and results of completion pneumonectomy. Eur J Cardiothorac Surg (2004) 1.68
Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res (2008) 1.66
Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol (2009) 1.66
End-of-life care in hospital: current practice and potentials for improvement. J Pain Symptom Manage (2007) 1.65
Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med (2014) 1.63
Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation (2002) 1.62
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail (2011) 1.61
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial. Breast Cancer Res Treat (2009) 1.61
Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant (2002) 1.60
Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol (2010) 1.59
Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg (2004) 1.57
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol (2013) 1.56
Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J (2006) 1.55
Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation. Transplantation (2004) 1.53
A stress-coping model of mental illness stigma: I. Predictors of cognitive stress appraisal. Schizophr Res (2009) 1.52
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol (2008) 1.51
Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters. Am Heart J (2003) 1.51
Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Cardiovasc Res (2005) 1.51
Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol (2006) 1.50
Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol (2008) 1.50
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2015) 1.49
Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost (2008) 1.45
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Mortality in patients with atrial fibrillation has significantly decreased during the last three decades: 35 years of follow-up in 1627 pacemaker patients. Europace (2008) 1.38
A stress-coping model of mental illness stigma: II. Emotional stress responses, coping behavior and outcome. Schizophr Res (2009) 1.32
Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax (2010) 1.30
Self-stigma, group identification, perceived legitimacy of discrimination and mental health service use. Br J Psychiatry (2009) 1.28
Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol (2007) 1.26
Wound complications after median sternotomy: a single-centre study. Interact Cardiovasc Thorac Surg (2013) 1.24
Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet (2010) 1.23
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res (2010) 1.22
Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res (2002) 1.21
Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Hepatology (2007) 1.19
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res (2004) 1.18
In situ calibration of nucleoplasmic versus cytoplasmic Ca²+ concentration in adult cardiomyocytes. Biophys J (2011) 1.17
Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke. Stroke (2010) 1.16
Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med (2008) 1.16
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol (2003) 1.16
Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol (2003) 1.15
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. Int J Cancer (2008) 1.15
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res (2012) 1.14
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail (2014) 1.13
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery (2004) 1.13
PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med (2004) 1.13
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol (2005) 1.12
Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J (2010) 1.11
Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores. J Cell Sci (2007) 1.10
EGFR and HER2 expression in advanced biliary tract cancer. World J Gastroenterol (2009) 1.08
Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: a novel diagnostic method. Eur Heart J (2005) 1.08
Functional relevance of the stretch-dependent slow force response in failing human myocardium. Circ Res (2004) 1.07
Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells. Antivir Ther (2003) 1.07
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol (2009) 1.06
Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters! J Am Coll Cardiol (2016) 1.06
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation (2007) 1.06
Thrombolysis for pulmonary embolism: Past, present and future. Thromb Haemost (2010) 1.05
Risk factors and complications following percutaneous endoscopic gastrostomy: a case series of 1041 patients. Can J Gastroenterol (2011) 1.05
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism (2013) 1.04